{"id":1790,"date":"2019-09-19T13:40:46","date_gmt":"2019-09-19T11:40:46","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=1790"},"modified":"2025-01-31T15:16:52","modified_gmt":"2025-01-31T14:16:52","slug":"hematopoyetic-and-lymphoid-tumors","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/research\/cancer-area\/molecular-mechanisms-and-experimental-therapy-in-oncology-program-oncobell\/hematopoyetic-and-lymphoid-tumors\/","title":{"rendered":"Hematopoyetic and lymphoid tumors"},"content":{"rendered":"\n

\n\t\tHematopoyetic and lymphoid tumors\n\t<\/h1>\n

\n\t\tSummary\n\t<\/h3>\n\t
\n

The Haematopoietic and Lymphoid Tumours group studies various types of tumours of the blood, their characteristics and patient responses to treatment. The study of tumours originating in the bloodline includes lymphomas and leukaemia, which have a major impact at the populational level. The study of their origin and characteristics, as well as testing treatments for these tumours, involves creating laboratory models and studies with patients (clinical trials).<\/p>\n<\/section>\n

\n\n<\/section>\n

1397<\/h2>\n

Publications<\/h2>\n\t\t\t\t\"all_-_peripherial_blood_-_diagnosis_-_01\"\n\t\t\t\t\tStrategic lines<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tClinical-biological correlations in lymphoid tumours
\nAlloreactivity and chimerism
\nMinimal residual disease
\nNew therapeutic targets
\nInfections in neutropenic patients
\nLymphomas following solid-organ transplant
\nAcute leukaemia
\nChronic myeloproliferative syndromes\n\t\t\t\t\tSelected Publications<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t